1. Home
  2. ACRV vs APT Comparison

ACRV vs APT Comparison

Compare ACRV & APT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACRV
  • APT
  • Stock Information
  • Founded
  • ACRV 2018
  • APT 1983
  • Country
  • ACRV United States
  • APT Canada
  • Employees
  • ACRV N/A
  • APT N/A
  • Industry
  • ACRV Medicinal Chemicals and Botanical Products
  • APT
  • Sector
  • ACRV Health Care
  • APT
  • Exchange
  • ACRV Nasdaq
  • APT Nasdaq
  • Market Cap
  • ACRV 59.9M
  • APT 61.6M
  • IPO Year
  • ACRV 2022
  • APT 1995
  • Fundamental
  • Price
  • ACRV $1.16
  • APT $4.68
  • Analyst Decision
  • ACRV Strong Buy
  • APT
  • Analyst Count
  • ACRV 5
  • APT 0
  • Target Price
  • ACRV $19.75
  • APT N/A
  • AVG Volume (30 Days)
  • ACRV 1.3M
  • APT 13.1K
  • Earning Date
  • ACRV 05-20-2025
  • APT 05-08-2025
  • Dividend Yield
  • ACRV N/A
  • APT N/A
  • EPS Growth
  • ACRV N/A
  • APT 2.28
  • EPS
  • ACRV N/A
  • APT 0.36
  • Revenue
  • ACRV N/A
  • APT $58,180,000.00
  • Revenue This Year
  • ACRV N/A
  • APT N/A
  • Revenue Next Year
  • ACRV N/A
  • APT N/A
  • P/E Ratio
  • ACRV N/A
  • APT $12.87
  • Revenue Growth
  • ACRV N/A
  • APT N/A
  • 52 Week Low
  • ACRV $1.30
  • APT $4.06
  • 52 Week High
  • ACRV $10.29
  • APT $6.44
  • Technical
  • Relative Strength Index (RSI)
  • ACRV 28.93
  • APT 57.72
  • Support Level
  • ACRV $1.32
  • APT $4.38
  • Resistance Level
  • ACRV $1.50
  • APT $4.66
  • Average True Range (ATR)
  • ACRV 0.17
  • APT 0.14
  • MACD
  • ACRV 0.06
  • APT 0.06
  • Stochastic Oscillator
  • ACRV 1.55
  • APT 97.73

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

About APT Alpha Pro Tech Ltd.

Alpha Pro Tech Ltd is involved in the business of developing, manufacturing, and marketing of disposable protective apparel, building supply, and infection control products principally in the United States. It operates its business through segment which includes Building Supply and Disposable Protective Apparel. It mainly offers a line of construction supply weatherization products, namely house wrap and synthetic roof underlayment as well as other woven material, different styles of disposable products like shoe covers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. It also provides face masks and eye shields. It generates most of its revenues from the sale of products across the United States.

Share on Social Networks: